mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
7e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.24 |
4e-06 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-06 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
9e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.0004 |